RxDoctor Payments Data

Tyson Kinnick, PhD

Physician Assistant · Alamosa, CONPI 1881019925

Payments from drug & device makers

$284in general payments, 2019–2025

Across 12 payments — averaging $23.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$53
  • Corcept Therapeutics$47
  • AbbVie$33
  • Edwards Lifesciences$27
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$24
  • Teva Pharmaceuticals USA, Inc.$23
  • plus $79 from 4 others

What the payments were for

  • Food & beverage$25289%
  • Education$3211%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$284 in reported general payments places this provider in the 55th percentile of 2,849 physician assistant providers in Colorado.

See all physician assistant providers in Colorado

Medicare billing

Part B allowed, 2024
$6,511
Medicare patients
43
Services billed
109

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide60$66,689
OzempicSemaglutide33$42,027
FarxigaDapagliflozin Propanediol12$20,295
JardianceEmpagliflozin14$17,804
Spiriva HandihalerTiotropium Bromide15$9,369
Lantus SolostarInsulin Glargine,hum.Rec.Anlog54$9,163
Tresiba Flextouch U-100Insulin Degludec12$6,606
Fluticasone-SalmeterolFluticasone Propion/Salmeterol24$4,983
SymbicortBudesonide/Formoterol Fumarate12$3,692
Albuterol Sulfate HfaAlbuterol Sulfate42$1,527
Fluticasone Propionate20$1,335
Candesartan Cilexetil15$1,321
Atorvastatin Calcium165$1,312
Nano 2nd Gen Pen NeedlePen Needle, Diabetic18$1,261
Omeprazole83$978

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$22$66,68960 claims
Novo NordiskOzempic$53$42,02733 claims
AstraZenecaFarxiga, Symbicort$21$23,98724 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 2,849 physician assistant providers in Colorado.

Other physician assistant in Alamosa

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →